COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
Study Information
Study Attribute Value
CEBS Accession Number: 002-01149-0002-0000-9
Chemical Name: 2',3'-Dideoxyinosine (AIDS Initiative)
CASRN: 69655-05-6
NTP Study Type: Genetic Toxicology - Mammalian Cell Cytogenetics
NTP Study ID: 705410_CA
Study Result: Negative

Study Result: Negative
Activation Trial Trial Call
No Activation  Positive 
Induced Rat Liver S9  1_S9  Negative 
No Activation  Negative 

Trial #:1   Activation: No Activation    Date: 01/11/1990    Harvest Time: 14.7 hour(s)   Trial Call: Positive   
  Dose
µg/mL
Total
Cells Examined
Total Aberrations Complex Aberrations Simple Aberrations Other Abs
No. of
Abs
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
Vehicle Control: Negative (Not Specified)
0         
200 1 0.005 0.5 0 0.000 0.0 1 0.005 0.5 0 0.000 0.0
Dimethyl Sulfoxide
0         
200 0 0.000 0.0 0 0.000 0.0 0 0.000 0.0 0 0.000 0.0
Test Chemical: 2',3'-Dideoxyinosine (AIDS Initiative)
270         
200 2 0.010 1.0 2 0.010 1.0 0 0.000 0.0 0 0.000 0.0
581         
200 5 0.025 2.5 3 0.015 1.5 2 0.010 1.0 0 0.000 0.0
1250         
200 6 0.030 3.0 2 0.010 1.0 4 0.020 2.0 0 0.000 0.0
Positive Control: Mitomycin-C
 0.4       
25 24 0.960 44.0 9 0.360 32.0 5 0.200 16.0 10 0.400 4.0
Trend: 2.626 1.188 2.566  
Probability: 0.004 0.117 0.005  


Trial #:1_S9   Activation: Induced Rat Liver S9    Date: 01/11/1990    Harvest Time: 13 hour(s)   Trial Call: Negative   
  Dose
µg/mL
Total
Cells Examined
Total Aberrations Complex Aberrations Simple Aberrations Other Abs
No. of
Abs
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
Vehicle Control: Negative (Not Specified)
0         
200 5 0.025 2.5 4 0.020 2.0 1 0.005 0.5 0 0.000 0.0
Dimethyl Sulfoxide
0         
200 2 0.010 1.0 1 0.005 0.5 1 0.005 0.5 0 0.000 0.0
Test Chemical: 2',3'-Dideoxyinosine (AIDS Initiative)
270         
200 4 0.020 2.0 2 0.010 1.0 2 0.010 1.0 0 0.000 0.0
581         
200 7 0.035 3.0 5 0.025 2.0 2 0.010 1.0 0 0.000 0.0
1250         
200 7 0.035 3.0 6 0.030 2.5 1 0.005 0.5 0 0.000 0.0
Positive Control: Cyclophosphamide
20         
25 15 0.600 40.0 9 0.360 32.0 6 0.240 12.0 0 0.000 0.0
Trend: 1.493 1.821 0.000  
Probability: 0.068 0.034 0.500  


Trial #:2   Activation: No Activation    Date: 02/15/1990    Harvest Time: 19.7 hour(s)   Trial Call: Negative   
  Dose
µg/mL
Total
Cells Examined
Total Aberrations Complex Aberrations Simple Aberrations Other Abs
No. of
Abs
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
Vehicle Control: Dimethyl Sulfoxide
0         
200 2 0.010 1.0 2 0.010 1.0 0 0.000 0.0 0 0.000 0.0
Negative (Not Specified)
0         
200 1 0.005 0.5 1 0.005 0.5 0 0.000 0.0 0 0.000 0.0
Test Chemical: 2',3'-Dideoxyinosine (AIDS Initiative)
270         
200 1 0.005 0.5 1 0.005 0.5 0 0.000 0.0 0 0.000 0.0
581         
200 5 0.025 2.5 2 0.010 1.0 3 0.015 1.5 0 0.000 0.0
1250         
200 8 0.040 4.0 4 0.020 2.0 4 0.020 2.0 0 0.000 0.0
Positive Control: Mitomycin-C
 0.4       
25 33 1.320 68.0 11 0.440 36.0 12 0.480 44.0 10 0.400 4.0
Trend: 2.485 1.049 2.547  
Probability: 0.006 0.147 0.005